×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

Covid-19 pill Paxlovid moves closer to full approval

Vocalize Pre-Player Loader

Audio By Vocalize

Doses of the anti-viral drug Paxlovid are displayed in New York, on August 1, 2022. [AP photo]

Pfizer's COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration.

The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the final say on giving Pfizer's drug full approval and is expected to decide by May.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
By AFP 6 hrs ago
Sports
LeBron's Lakers eliminated from NBA playoffs as Thunder seal sweep
Sports
Tergat, Loroupe say Africa Summit is key for local sports
Sports
Safaricom launches fifth Chapa Dimba season with Sweden opportunity
Sports
Mokaya, Moraa and Kongani shine at Mother's Day golf tournament in Kisumu